BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 28652767)

  • 1. Prognostic value of high IMP3 expression in solid tumors: a meta-analysis.
    Chen L; Xie Y; Li X; Gu L; Gao Y; Tang L; Chen J; Zhang X
    Onco Targets Ther; 2017; 10():2849-2863. PubMed ID: 28652767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of octamer binding transcription factor 4 for patients with solid tumors: A meta-analysis.
    Zhao X; Lu H; Sun Y; Liu L; Wang H
    Medicine (Baltimore); 2020 Oct; 99(42):e22804. PubMed ID: 33080755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of Kindlin-2 expression in patients with solid tumors: a meta-analysis.
    Liu S; Chen S; Ma K; Shao Z
    Cancer Cell Int; 2018; 18():166. PubMed ID: 30386175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of circulating tumor cells associated with white blood cells in solid cancer: a systematic review and meta-analysis of 1471 patients with solid tumors.
    Ju M; Gao Z; Gu G; Huang H; Sun A; Zheng C; Li H; Zhang Y; Li K
    BMC Cancer; 2023 Dec; 23(1):1224. PubMed ID: 38087278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Prognostic Value of Decreased LKB1 in Solid Tumors: A Meta-Analysis.
    Xiao J; Zou Y; Chen X; Gao Y; Xie M; Lu X; Li W; He B; He S; You S; Chen Q
    PLoS One; 2016; 11(4):e0152674. PubMed ID: 27035914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Significance of the Metabolic Marker Hexokinase-2 in Various Solid Tumors: A Meta-Analysis.
    Liu Y; Wu K; Shi L; Xiang F; Tao K; Wang G
    PLoS One; 2016; 11(11):e0166230. PubMed ID: 27824926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Change of Circulating and Tissue-Based miR-20a in Human Cancers and Associated Prognostic Implication: A Systematic Review and Meta-Analysis.
    Zhang Q; Wang Q; Sun W; Gao F; Liu L; Cheng L; Li Z
    Biomed Res Int; 2018; 2018():6124927. PubMed ID: 30596096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis as a prognostic variable for the clinical outcome in patients with renal cell carcinoma: a systematic review and meta-analysis.
    Zhang L; Zha Z; Qu W; Zhao H; Yuan J; Feng Y; Wu B
    BMC Cancer; 2018 Sep; 18(1):870. PubMed ID: 30176824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic nutritional index and prognosis in renal cell carcinoma: A systematic review and meta-analysis.
    Kim SI; Kim SJ; Kim SJ; Cho DS
    Urol Oncol; 2021 Oct; 39(10):623-630. PubMed ID: 34253447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Significance of Pretreatment Apolipoprotein A-I as a Noninvasive Biomarker in Cancer Survivors: A Meta-Analysis.
    Zhang Y; Yang X
    Dis Markers; 2018; 2018():1034037. PubMed ID: 30510601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-treatment Glasgow prognostic score and modified Glasgow prognostic score may be potential prognostic biomarkers in urological cancers: a systematic review and meta-analysis.
    Qi F; Xu Y; Zheng Y; Li X; Gao Y
    Ann Transl Med; 2019 Oct; 7(20):531. PubMed ID: 31807513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Significance Role of microRNA-200c as a Prognostic Factor in Various Human Solid Malignant Neoplasms: A Meta-Analysis.
    Wang F; Zhang L; Xu H; Li R; Xu L; Qin Z; Zhong B
    J Cancer; 2019; 10(1):277-286. PubMed ID: 30662548
    [No Abstract]   [Full Text] [Related]  

  • 13. Prognostic Value of Long Noncoding RNA CRNDE as a Novel Biomarker in Solid Cancers: An Updated Systematic Review and Meta-Analysis.
    Zhou Y; Wang R; Xu T; Xie P; Zhang Y; Zhang A; Wang X; Yang C; Yang H; Zhu S
    J Cancer; 2019; 10(11):2386-2396. PubMed ID: 31258743
    [No Abstract]   [Full Text] [Related]  

  • 14. Upregulated SOX9 expression indicates worse prognosis in solid tumors: a systematic review and meta-analysis.
    Ruan H; Hu S; Zhang H; Du G; Li X; Li X; Li X
    Oncotarget; 2017 Dec; 8(68):113163-113173. PubMed ID: 29348895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galectin-9 Expression Predicts Favorable Clinical Outcome in Solid Tumors: A Systematic Review and Meta-Analysis.
    Zhou X; Sun L; Jing D; Xu G; Zhang J; Lin L; Zhao J; Yao Z; Lin H
    Front Physiol; 2018; 9():452. PubMed ID: 29765332
    [No Abstract]   [Full Text] [Related]  

  • 16. Correlation Between PD-L2 Expression and Clinical Outcome in Solid Cancer Patients: A Meta-Analysis.
    Yang H; Zhou X; Sun L; Mao Y
    Front Oncol; 2019; 9():47. PubMed ID: 30891423
    [No Abstract]   [Full Text] [Related]  

  • 17. IMP3 is a novel prognostic marker that correlates with colon cancer progression and pathogenesis.
    Li D; Yan D; Tang H; Zhou C; Fan J; Li S; Wang X; Xia J; Huang F; Qiu G; Peng Z
    Ann Surg Oncol; 2009 Dec; 16(12):3499-506. PubMed ID: 19672661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of serum amyloid A in solid tumors: a meta-analysis.
    Lin HY; Tan GQ; Liu Y; Lin SQ
    Cancer Cell Int; 2019; 19():62. PubMed ID: 30930691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of HHLA2 expression in solid tumors: A meta-analysis based on the Chinese population.
    Zhang C; Xu J; Ye J; Zhang X
    Medicine (Baltimore); 2021 Jul; 100(30):e26789. PubMed ID: 34397730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of pretreatment controlling nutritional status score in urological cancers: a systematic review and meta-analysis.
    Niu X; Zhu Z; Bao J
    Cancer Cell Int; 2021 Feb; 21(1):126. PubMed ID: 33608012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.